• Text Resize A A A
  • Print Print
  • Share Share on facebook Share on twitter Share
FOR IMMEDIATE RELEASE
October 15, 2018
Contact: HHS Press Office
202-690-6343
media@hhs.gov

HHS Secretary Azar Comments on Drug Industry Price Transparency Announcement

Health and Human Services Secretary Alex Azar issued the following statement regarding pharmaceutical companies’ announcement that they would be providing access to more information on drug prices:

“Patient empowerment and transparency are at the core of the President’s drug-pricing blueprint that was released five months ago. Our vision for a new, more transparent drug-pricing system does not rely on voluntary action. The drug industry remains resistant to providing real transparency around their prices, including the sky-high list prices that many patients pay. So while the pharmaceutical industry’s action today is a small step in the right direction, we will go further and continue to implement the President’s blueprint to deliver new transparency and put American patients first. “ 

###
Note: All HHS press releases, fact sheets and other news materials are available at https://www.hhs.gov/news.
Like HHS on Facebook Exit disclaimer icon, follow HHS on Twitter @HHSgov Exit disclaimer icon, and sign up for HHS Email Updates.
Last revised: October 15, 2018

Subscribe to RSS

Receive latest updates

Subscribe to our RSS